Health News

Researchers develop dual-targeting drug for EBV-related cancers

A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV). The peptide-linked drug, which is responsive to the acidic environment found in tumors, is the first known agent to have successfully targeted two viral proteins that […]